Considering that the activation of PI3K–AKT–mTOR signalling can promote lipogenesis and glycolysis,24 we determined whether KDM6A could also regulate lipid and glucose metabolism re‐programming in HCC. The gene discussed is KDM6A; the disease is hepatocellular carcinoma.